These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 21936681

  • 1. Indacaterol.
    Donohue JF, Martinez FJ.
    COPD; 2011 Oct; 8(5):327-8. PubMed ID: 21936681
    [No Abstract] [Full Text] [Related]

  • 2. [Indacaterol (Onbrez Breezhaler), oral inhalation].
    Duh D, Tanret I.
    J Pharm Belg; 2011 Dec; (4):127-8. PubMed ID: 22299240
    [No Abstract] [Full Text] [Related]

  • 3. Indacterol (Arcapta Neohaler) for COPD.
    Med Lett Drugs Ther; 2012 Apr 30; 54(1389):33-5. PubMed ID: 22538621
    [No Abstract] [Full Text] [Related]

  • 4. Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD.
    Beeh KM, Wagner F, Khindri S, Drollmann AF.
    COPD; 2011 Oct 30; 8(5):340-5. PubMed ID: 21793716
    [Abstract] [Full Text] [Related]

  • 5. Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.
    Vogelmeier C, Magnussen H, LaForce C, Owen R, Kramer B.
    Ther Adv Respir Dis; 2011 Oct 30; 5(5):345-57. PubMed ID: 21719531
    [Abstract] [Full Text] [Related]

  • 6. Indacaterol: a novel long-acting β(2) -agonist.
    Ray SM, McMillen JC, Treadway SA, Helmer RS, Franks AS.
    Pharmacotherapy; 2012 May 30; 32(5):456-74. PubMed ID: 22499359
    [Abstract] [Full Text] [Related]

  • 7. [Medication of the month. Indacaterol (Onbrez Breezhaler) and chronic obstructive pulmonary disease].
    Corhay JL, Louis R.
    Rev Med Liege; 2011 Sep 30; 66(9):498-502. PubMed ID: 21995240
    [Abstract] [Full Text] [Related]

  • 8. Indacaterol Novartis/skyePharma.
    Currie GP.
    Curr Opin Investig Drugs; 2006 May 30; 7(5):457-63. PubMed ID: 16729723
    [Abstract] [Full Text] [Related]

  • 9. An update on the use of indacaterol in patients with COPD.
    Brienza NS, Amor-Carro O, Ramos-Barbón D.
    Ther Adv Respir Dis; 2011 Feb 30; 5(1):29-40. PubMed ID: 21059700
    [Abstract] [Full Text] [Related]

  • 10. Indacaterol/Glycopyrronium in Clinical Practice: The Italian Experience.
    Cazzola M.
    Respiration; 2018 Feb 30; 95 Suppl 1():1-2. PubMed ID: 29705778
    [No Abstract] [Full Text] [Related]

  • 11. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
    Beeh KM, Beier J.
    Adv Ther; 2009 Jul 30; 26(7):691-9. PubMed ID: 19609496
    [Abstract] [Full Text] [Related]

  • 12. Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol.
    Pavkov R, Mueller S, Fiebich K, Singh D, Stowasser F, Pignatelli G, Walter B, Ziegler D, Dalvi M, Dederichs J, Rietveld I.
    Curr Med Res Opin; 2010 Nov 30; 26(11):2527-33. PubMed ID: 20843166
    [Abstract] [Full Text] [Related]

  • 13. QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease.
    van Noord JA, Buhl R, Laforce C, Martin C, Jones F, Dolker M, Overend T.
    Thorax; 2010 Dec 30; 65(12):1086-91. PubMed ID: 20978028
    [Abstract] [Full Text] [Related]

  • 14. Glycopyrronium + indacaterol. A fixed-dose combination with no advantages in COPD.
    Prescrire Int; 2014 Dec 30; 23(155):288. PubMed ID: 25629143
    [Abstract] [Full Text] [Related]

  • 15. Roflumilast, indacaterol maleate, and abiraterone acetate.
    Hussar DA, DePasquale J.
    J Am Pharm Assoc (2003); 2011 Dec 30; 51(5):668-71. PubMed ID: 21896467
    [No Abstract] [Full Text] [Related]

  • 16. Indacaterol maleate for the treatment of chronic obstructive pulmonary disease.
    Tashkin DP.
    Expert Opin Pharmacother; 2010 Aug 30; 11(12):2077-85. PubMed ID: 20642373
    [Abstract] [Full Text] [Related]

  • 17. A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients.
    Yelensky R, Li Y, Lewitzky S, Leroy E, Hurwitz C, Rodman D, Trifilieff A, Paulding CA.
    Pharmacogenomics J; 2012 Dec 30; 12(6):484-8. PubMed ID: 22158330
    [Abstract] [Full Text] [Related]

  • 18. Coexisting Heart Failure and Chronic Obstructive Pulmonary Disease: Report of Two Cases Treated with Indacaterol/Glycopyrronium.
    Cosentino ER, Degli Esposti D, Miceli R, Bentivenga C, Landolfo M, Ricci Iamino I, Spinardi L, Magri G, Borghi C.
    Respiration; 2018 Dec 30; 95 Suppl 1():3-5. PubMed ID: 29705784
    [Abstract] [Full Text] [Related]

  • 19. [Dual bronchodilators becomes the first choice combination].
    Einecke D.
    MMW Fortschr Med; 2016 Jun 09; 158(11):18. PubMed ID: 27271388
    [No Abstract] [Full Text] [Related]

  • 20. [Indacaterol is a new once-daily beta2-agonist for treatment of COPD].
    Ulrik CS.
    Ugeskr Laeger; 2010 Nov 22; 172(47):3260-3. PubMed ID: 21092722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.